Mary Clara Capel - 03 Feb 2026 Form 4 Insider Report for FIRST BANCORP /NC/ (FBNC)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
04 Feb 2026, 11:29:24 UTC
Prior SEC filing
03 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Anna L. Miller, Attorney in-fact

Key filing fact

Mary Clara Capel filed Form 4 for FIRST BANCORP /NC/ (FBNC) on 04 Feb 2026.

Key facts

  • This page summarizes Mary Clara Capel's Form 4 filing for FIRST BANCORP /NC/ (FBNC).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 04 Feb 2026, 11:29.

Change

  • Previous filing in this sequence was filed on 03 Feb 2026.
  • Current net transaction value: -$296,554.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001324937 Primary reporting owner

Capel Mary Clara

Relationship
Retired Board Member
Address
PO BOX 826, TROY
Signature
/s/ Anna L. Miller, Attorney in-fact
Signature date
04 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

FBNC transaction

Common Stock

Sale

Transaction value
$296,554
Shares
-5,000
Change %
-20%
Price
$59.31
Shares after
20,400
Date
03 Feb 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This transaction was executed in multiple trades at various prices, and filer will provide the full breakdown of prices upon request.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .